divestiture
Becton Dickinson to Spin Off Biosciences and Diagnostics Business as Q1 Revenues Grow 10 Percent
Premium
The separation is planned to be completed by the end of 2026 with the rest of the company transforming into a pure play medical technology firm.
OpGen Sells Customer Contracts, Installed MDx Instrument Base for $218K
The contracts and instrument base was acquired by Singapore-based Camtech, which had previously acquired OpGen's Curetis subsidiary during insolvency proceedings.
Synthego Divests Engineered Cell, CRISPR Guide RNA Business Into Separate Company
Following the move, Synthego intends to focus on therapeutic applications of CRISPR under a newly appointed CEO.
Inex Innovate Acquiring Yourgene Health's Taiwanese Genomics Business for up to $4M
Inex expects Yourgene Taiwan to provide it with additional capabilities in fetal health and oncology R&D, bioinformatics, biobanking, and clinical laboratory services.
The company is selling its applied, food, and enterprise services to New Mountain Capital for $2.45 billion in cash.
Dec 11, 2018
Novacyt to Sell Cytology, Clinical Lab Units
Jan 31, 2017
Hologic Completes Divestiture of Grifols for $1.85B
Dec 22, 2016
PerkinElmer Sells Medical Imaging Business for $276M
Dec 1, 2015
Transgenomic Completes Sale of GAP Business Unit
Dec 31, 2012
Quest Diagnostics Divests OralDNA Labs
Dec 13, 2012